Steven C. Pomerantz

2.0k total citations
33 papers, 1.7k citations indexed

About

Steven C. Pomerantz is a scholar working on Molecular Biology, Spectroscopy and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Steven C. Pomerantz has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Spectroscopy and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Steven C. Pomerantz's work include RNA modifications and cancer (15 papers), RNA and protein synthesis mechanisms (15 papers) and Mass Spectrometry Techniques and Applications (8 papers). Steven C. Pomerantz is often cited by papers focused on RNA modifications and cancer (15 papers), RNA and protein synthesis mechanisms (15 papers) and Mass Spectrometry Techniques and Applications (8 papers). Steven C. Pomerantz collaborates with scholars based in United States, Sweden and Philippines. Steven C. Pomerantz's co-authors include James A. McCloskey, Pamela F. Crain, Jeffrey A. Kowalak, Takeshi Hashizume, Jef Rozenski, Yizhou Zhang, P. F. Crain, Jinsong Ni, Charles G. Edmonds and Rebecca Guymon and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Steven C. Pomerantz

33 papers receiving 1.6k citations

Peers

Steven C. Pomerantz
Katherine A. Edmonds United States
Axel Lezius Germany
Aneika C. Leney United Kingdom
Mayo Uziel United States
Edouard S. P. Bouvier United States
Sharron L. Nance United States
Katherine A. Edmonds United States
Steven C. Pomerantz
Citations per year, relative to Steven C. Pomerantz Steven C. Pomerantz (= 1×) peers Katherine A. Edmonds

Countries citing papers authored by Steven C. Pomerantz

Since Specialization
Citations

This map shows the geographic impact of Steven C. Pomerantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. Pomerantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. Pomerantz more than expected).

Fields of papers citing papers by Steven C. Pomerantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. Pomerantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. Pomerantz. The network helps show where Steven C. Pomerantz may publish in the future.

Co-authorship network of co-authors of Steven C. Pomerantz

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. Pomerantz. A scholar is included among the top collaborators of Steven C. Pomerantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. Pomerantz. Steven C. Pomerantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zwolak, Adam, Szeman Ruby Chan, Anthony A. Armstrong, et al.. (2022). A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3. Scientific Reports. 12(1). 20538–20538. 5 indexed citations
2.
Pomerantz, Steven C., Omid Vafa, Michael Naso, et al.. (2015). Optimizing production of Fc-amidated peptides by Chinese hamster ovary cells. BMC Biotechnology. 15(1). 95–95. 7 indexed citations
3.
Pomerantz, Steven C., Jiali Li, Omid Vafa, et al.. (2015). Secretion of Fc-amidated peptide fusion proteins by Chinese hamster ovary cells. BMC Biotechnology. 15(1). 61–61. 5 indexed citations
4.
Janecki, Dariusz J., et al.. (2012). A fully integrated multi-column system for abundant protein depletion from serum/plasma. Journal of Chromatography B. 902. 35–41. 8 indexed citations
5.
Teplyakov, A., Galina Obmolova, Nicole Stowell, et al.. (2010). Synthesis by native chemical ligation and crystal structure of human CCL2. Biopolymers. 94(3). 350–359. 10 indexed citations
6.
Mills, Juliane K., Ken Boakye, Jinquan Luo, et al.. (2007). Expression and characterization of a human BMP-7 variant with improved biochemical properties. Protein Expression and Purification. 57(2). 312–319. 33 indexed citations
8.
Chen, Peng, Pamela F. Crain, Joakim Näsvall, Steven C. Pomerantz, & Glenn R. Björk. (2005). A 'gain of function' mutation in a protein mediates production of novel modified nucleosides. The EMBO Journal. 24(10). 1842–1851. 35 indexed citations
9.
Campo, Mark Del, Steven C. Pomerantz, Rebecca Guymon, et al.. (2005). Number, position, and significance of the pseudouridines in the large subunit ribosomal RNA of Haloarcula marismortui and Deinococcus radiodurans. RNA. 11(2). 210–219. 37 indexed citations
10.
Hagervall, Tord G., Steven C. Pomerantz, & James A. McCloskey. (1998). Reduced misreading of asparagine codons by Escherichia coli tRNA Lys with hypomodified derivatives of 5-methylaminomethyl-2-thiouridine in the wobble position 1 1Edited by D. E. Draper. Journal of Molecular Biology. 284(1). 33–42. 67 indexed citations
11.
Limbach, Patrick A., P. F. Crain, Steven C. Pomerantz, & James A. McCloskey. (1995). Structures of posttranscriptionally modified nucleosides from RNA. Biochimie. 77(1-2). 135–138. 16 indexed citations
12.
Yokogawa, Takashi, Takuya Ueda, Kazuya Nishikawa, et al.. (1994). A Novel Modified Nucleoside Found at the First Position of the Anticodon of Methionine tRNA from Bovine Liver Mitochondria. Biochemistry. 33(8). 2234–2239. 82 indexed citations
13.
Scharff, P., et al.. (1993). Editing does not exist for mammalian selenocysteine tRNAs. Nucleic Acids Research. 21(24). 5583–5588. 30 indexed citations
14.
Kowalak, Jeffrey A., Steven C. Pomerantz, Pamela F. Crain, & James A. McCloskey. (1993). A novel method for the determination of posttranscriptional modification in RNA by mass spectrometry. Nucleic Acids Research. 21(19). 4577–4585. 176 indexed citations
15.
Harker, W G, et al.. (1992). Isolation, purification, and characterization of two new chemical decomposition products of methylazoxyprocarbazine.. Drug Metabolism and Disposition. 20(5). 632–642. 6 indexed citations
16.
Polson, Andrew G., Pamela F. Crain, Steven C. Pomerantz, James A. McCloskey, & Brenda Bass. (1991). The mechanism of adenosine to inosine conversion by the double-stranded RNA unwinding/modifying activity: a high-performance liquid chromatography-mass spectrometry analysis. Biochemistry. 30(49). 11507–11514. 112 indexed citations
17.
Takeda, Naohito, Steven C. Pomerantz, & James A. McCloskey. (1991). Detection of ribose-methylated nucleotides in enzymatic hydrolysates of RNA by thermospray liquid chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 562(1-2). 225–235. 14 indexed citations
18.
Pomerantz, Steven C. & James A. McCloskey. (1990). [44] Analysis of RNA hydrolyzates by liquid chromatography-mass spectrometry. Methods in enzymology on CD-ROM/Methods in enzymology. 193. 796–824. 198 indexed citations
19.
Hashizume, Takeshi, Chad Nelson, Steven C. Pomerantz, & James A. McCloskey. (1990). Applications of LC/MS and Tandem Mass Spectrometry to the Characterization of Nucleosides in Mixtures. Nucleosides and Nucleotides. 9(3). 355–359. 4 indexed citations
20.
Pomerantz, Steven C. & James A. McCloskey. (1987). Fractional mass values of large molecules. Organic Mass Spectrometry. 22(5). 251–253. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026